External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ASGCT 2025

-
Coming soon
10:30 PM
Duration 90mins New Orleans, USA
Assessment of Cardiac Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy
Aravindhan Veerapandiyan, John Bourke, John Day, Craig McDonald, Jerry Mendell, Jonathan Soslow, Craig Zaidman, Stefanie Mason, Sravya Ennamuri, Jianfeng Meng, Mark Vivien, Tao Niu, Alexander P. Murphy, Christoph Wandel, James Richardson

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 90mins New Orleans, USA
3-Year Functional Outcomes of Patients With Duchenne Muscular Dystrophy: Pooled Delandistrogene Moxeparvovec Clinical Trial Data vs External Controls
Jerry Mendell, Anne M. Connolly, John Day, Craig McDonald, Crystal Proud, Perry Shieh, Craig Zaidman, Matthew Furgerson, Sravya Ennamuri, Kai Ding, Carol Reid, Alexander P. Murphy, Jacob S. Elkins, Louise Rodino-Klapac

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:45 PM
Duration 15mins Room: 393-396
Long-Term Functional Outcomes and Safety Following Delandistrogene Moxeparvovec Treatment in DMD: EMBARK 2-Year Results
Jerry R. Mendell, Francesco Muntoni, Craig M. McDonald, Eugenio M. Mercuri, Emma Ciafaloni, Hirofumi Komaki, Carmen Leon-Astudillo, Andrés Nascimento, Crystal Proud, Ulrike Schara-Schmidt, Aravindhan Veerapandiyan, Craig M. Zaidman, Matthew Furgerson, Kai Ding, Preeti Singh, Rachael Potter, Damon R. Asher, Alexander P. Murphy, Carol Reid, Gregory Hooper, Carmen O. Torre, Marianna Manfrini, Louise R. Rodino-Klapac, on behalf of the EMBARK Study Group

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar